Stevanato Group SpA (STU:87N) ROCE %: 7.76% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:87N Stevanato Group SpA STU:87N
88 GF Score
Price €17.30
GF Value €22.17
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Stevanato Group SpA ROCE %?

Stevanato Group SpA STU:87N 88 ROCE % is 7.76% as of Jun. 2026. GuruFocus rates STU:87N with a GF Score™ of 88/100 and a GF Value™ of €22.17 (Modestly Undervalued). The stock has 6 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Stevanato Group SpA's annualized ROCE % for the quarter that ended in Jun. 2026 was 7.76%.

Stevanato Group SpA  (STU:87N) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Stevanato Group SpA ROCE % Related Terms

Stevanato Group SpA ROCE % Historical Data

* Premium members only.

The historical data trend for Stevanato Group SpA's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stevanato Group SpA ROCE % Chart

Stevanato Group SpA Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial 19.69 16.82 14.39 9.98 10.14

Stevanato Group SpA Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.75 10.67 13.63 8.35 7.76
STU:87N
88GF Score
Stevanato Group SpA STU:87N
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Stevanato Group SpA ROCE % Calculation

Stevanato Group SpA's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=195.589/( ( (2328.819 - 477.474) + (2543.974 - 535.878) )/ 2 )
=195.589/( (1851.345+2008.096)/ 2 )
=195.589/1929.7205
=10.14 %

Stevanato Group SpA's ROCE % of for the quarter that ended in Jun. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Jun. 2026 )  (Q: Mar. 2026 )(Q: Jun. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Jun. 2026 )  (Q: Mar. 2026 )(Q: Jun. 2026 )
=157.608/( ( (2583.821 - 560.268) + (2618.744 - 578.261) )/ 2 )
=157.608/( ( 2023.553 + 2040.483 )/ 2 )
=157.608/2032.018
=7.76 %

(1) Note: The EBIT data used here is four times the quarterly (Jun. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 7.76% mean?
Stevanato Group SpA (STU:87N) has a ROCE % of 7.76% as of Jun. 2026.
Is Stevanato Group SpA's ROCE % too high?
Stevanato Group SpA's current ROCE % is 7.76%. The Medical Devices & Instruments industry median ROCE % is 2.97. Stevanato Group SpA's value of 7.76% is 161.3% above this industry median. Overall, Stevanato Group SpA has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Stevanato Group SpA's ROCE % compare to MMED and TFX?
Stevanato Group SpA's ROCE % of 7.76% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.97. Stevanato Group SpA's value of 7.76% is 161.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.97, based on 811 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Stevanato Group SpA's current ROCE % of 7.76% is 161.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Stevanato Group SpA's current ROCE % is 7.76%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stevanato Group SpA stock overvalued right now?
Based on GuruFocus' analysis, Stevanato Group SpA (STU:87N) is currently considered Modestly Undervalued. The stock's GF Value™ is €22.17, compared to a current price of €17.30 — trading 22% below its estimated fair value. The current ROCE % is 7.76% and 161.3% above the Medical Devices & Instruments industry median of 2.97. Stevanato Group SpA's overall GF Score™ is 88/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Stevanato Group SpA (STU:87N), the current ROCE % is 7.76% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Stevanato Group SpA (STU:87N) Overvalued in 2026?

Based on GuruFocus' analysis, Stevanato Group SpA stock appears to be undervalued. The current stock price of €17.30 is trading 22% below its estimated GF Value™ of €22.17. GuruFocus considers Stevanato Group SpA to be Modestly Undervalued.

Key valuation signals for STU:87N:

  • ROCE %: 7.76%
  • GF Value™: €22.17 vs. price of €17.30 (22% below fair value)
  • GF Score™: 88/100 with 6 warning signs
  • Industry Position: 161.3% above the Medical Devices & Instruments median

No single metric tells the full story. See the STU:87N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Stevanato Group SpA Business Description

Other Exchanges STVN:USA
Address Via Molinella 17, Piombino Dese, Padua, ITA, 35017
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.
88GF Score

Get the complete analysis for STU:87N

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€17.30
Price
€22.17
GF Value